share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  2024/11/09 05:14

Moomoo AI 已提取核心信息

Titan Pharmaceuticals announced on November 6, 2024, that its Board of Directors has appointed current director Brynner Chiam as acting principal executive officer and acting principal financial officer. Chiam will maintain his position on the company's Board while serving in these dual roles. The company has initiated a search for a permanent CEO.Chiam, 47, brings over 20 years of experience as a tax consultant and practitioner. He currently serves as Tax Director at Black Chamber Management since November 2020, following his previous role as Director at Tricor Taxand from 2014 to 2020. He holds a Bachelor of Business Studies in Accountancy from Massey University and is a member of the Chartered Tax Institute of Malaysia. No additional compensation or employment agreement has been established for his new executive roles.
Titan Pharmaceuticals announced on November 6, 2024, that its Board of Directors has appointed current director Brynner Chiam as acting principal executive officer and acting principal financial officer. Chiam will maintain his position on the company's Board while serving in these dual roles. The company has initiated a search for a permanent CEO.Chiam, 47, brings over 20 years of experience as a tax consultant and practitioner. He currently serves as Tax Director at Black Chamber Management since November 2020, following his previous role as Director at Tricor Taxand from 2014 to 2020. He holds a Bachelor of Business Studies in Accountancy from Massey University and is a member of the Chartered Tax Institute of Malaysia. No additional compensation or employment agreement has been established for his new executive roles.
泰坦制药于2024年11月6日宣布,董事会已任命现任董事Brynner Chiam为临时首席执行官和临时首席财务官。Chiam将在担任这两个职务的同时,继续保留他在公司董事会的职位。公司已启动寻找永久首席执行官的工作。现年47岁的Chiam拥有超过20年的税务顾问和从业经验。自2020年11月以来,他担任Black Chamber Management的税务总监,此前从2014年到2020年担任Tricor Taxand的董事。他获得了梅西大学的会计学学士学位,并且是马来西亚特许税务学院的成员。没有为他的新职务设定额外的薪酬或雇佣协议。
泰坦制药于2024年11月6日宣布,董事会已任命现任董事Brynner Chiam为临时首席执行官和临时首席财务官。Chiam将在担任这两个职务的同时,继续保留他在公司董事会的职位。公司已启动寻找永久首席执行官的工作。现年47岁的Chiam拥有超过20年的税务顾问和从业经验。自2020年11月以来,他担任Black Chamber Management的税务总监,此前从2014年到2020年担任Tricor Taxand的董事。他获得了梅西大学的会计学学士学位,并且是马来西亚特许税务学院的成员。没有为他的新职务设定额外的薪酬或雇佣协议。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息